Roche

Roche, a global leader dedicated to enhancing lives, has been at the forefront of healthcare innovation for over 125 years. Based in Basel, Switzerland, Roche focuses on developing groundbreaking medicines and cutting-edge diagnostic solutions to address a wide range of health challenges. In New Zealand, Roche operates through two key divisions: Roche Pharmaceuticals and Roche Diagnostics.

With a commitment to personalized healthcare, Roche aims to provide tailored treatments that cater to the unique needs of each individual. Their portfolio includes 27 available medicines in New Zealand, with 16 funded through Pharmac. Notably, Roche is a significant contributor to clinical research globally, with Aotearoa New Zealand serving as a key hub for research and development initiatives.

By investing in local trials and development, Roche continues to make a significant impact, having treated over 11,000 patients in 2022 alone. Discover the transformative impact of Roche's innovative solutions in reshaping healthcare for better outcomes